Recent insider trading activity from Hoyos Rocio Martin, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 20, 2026 | Atrium Therapeutics, Inc. | $RNA | Hoyos Rocio Martin | Chief Strategy Officer | A | Common Stock | 30000 | $0.00 | 46,660.0000 | 0 | 180.07% | 0.00% |
| April 20, 2026 | Atrium Therapeutics, Inc. | $RNA | Hoyos Rocio Martin | Chief Strategy Officer | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |